A Pase II/III Trial of Neoadjuvant FOLFOX with Selective Use of Combined Modality Chemoradiation versus Prepoperative Combined Modaligy Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing
Sponsoring Agencies:
NATL INST OF HLTH NC, NATL SURG ADJUV BREAST & BOWE
